<DOC>
	<DOCNO>NCT01203540</DOCNO>
	<brief_summary>Multicentre , Double blind , Randomized , Comparative Study ( compare N-acetyl-aspartyl-glutamic acid ( NAAGA ) Abak preservative free device versus SALINE Abak preservative free device . Evaluation effect safety NAABAK® inflammation marker symptoms patient allergic conjunctivitis dry eye syndrome 3 month treatment . The patient attend 4 visit .</brief_summary>
	<brief_title>Evaluation Effect Tolerance Preservative Free NAAGA Inflammatory Component Symptoms Dry Eye Syndrome Allergic Conjunctivitis Patients</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Age ≥ 20 year old Patients dry eye syndrome allergic conjunctivitis Severe dry eye syndrome Severe ocular pathology</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>